Control Bionics Secures FDA Registration for NeuroStrip Wearable Platform

· smallcaps.com.au

Control Bionics wins FDA registration for NeuroStrip, boosting regulatory credibility and accelerating growth in Performance, Rehab, and Research.

Control Bionics (ASX: CBL) has registered and listed its NeuroStrip surface electromyography wearable platform with the US Food and Drug Administration as a med...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI